Friday, June 8, 2012

New Myeloma Drug Looks Promising

CHICAGO – The investigational oral proteasome inhibitor MLN9708 showed hints of promise in multiple myeloma patients who are relapsed or refractory to treatment, investigators in a small phase I study reported here.


JUMP

No comments: